Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1979;7(Suppl 2):161S–166S. doi: 10.1111/j.1365-2125.1979.tb04686.x

Improved physical performance as a therapeutic objective in patients with angina

A S C Ling, J T Groel
PMCID: PMC1429329  PMID: 37870

Abstract

1 Improvement in physical performance, based on exercise tolerance, self-assessed work and physician-rated functional capacities, is proposed as a measure of efficacy of anti-anginal therapy in the rehabilitation of the cardiac patient.

2 Improved physical performance parallels changes in frequency of anginal attacks and a nitroglycerin requirements following β-blocker therapy.

3 Nadolol (a β-blocker), given once daily is as effective as propranolol, given four times daily as an anti-anginal agent.

Full text

PDF
161S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aronow W. S. Treatment of angina pectoris. Pharmacologic approaches. Postgrad Med. 1976 Nov;60(5):100–106. doi: 10.1080/00325481.1976.11714477. [DOI] [PubMed] [Google Scholar]
  2. BLACK J. W., CROWTHER A. F., SHANKS R. G., SMITH L. H., DORNHORST A. C. A NEW ADRENERGIC BETARECEPTOR ANTAGONIST. Lancet. 1964 May 16;1(7342):1080–1081. doi: 10.1016/s0140-6736(64)91275-9. [DOI] [PubMed] [Google Scholar]
  3. Bodem G., Chidsey C. A. Pharmacokinetic studies of practolol, a beta adrenergic antagonist, in man. Clin Pharmacol Ther. 1973 Jan-Feb;14(1):26–29. doi: 10.1002/cpt197314126. [DOI] [PubMed] [Google Scholar]
  4. Conolly M. E., Kersting F., Dollery C. T. The clinical pharmacology of beta-adrenoceptor-blocking drugs. Prog Cardiovasc Dis. 1976 Nov-Dec;19(3):203–234. doi: 10.1016/0033-0620(76)90016-5. [DOI] [PubMed] [Google Scholar]
  5. DORNHORST A. C., ROBINSON B. F. Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide). Lancet. 1962 Aug 18;2(7251):314–316. doi: 10.1016/s0140-6736(62)90104-6. [DOI] [PubMed] [Google Scholar]
  6. Dreyfuss J., Brannick L. J., Vukovich R. A., Shaw J. M., Willard D. A. Metabolic studies in patients with nadolol: oral and intravenous administration. J Clin Pharmacol. 1977 May-Jun;17(5-6):300–307. doi: 10.1002/j.1552-4604.1977.tb04609.x. [DOI] [PubMed] [Google Scholar]
  7. Friedberg C. K. Some comments and reflections on changing interests and new developments in angina pectoris. Circulation. 1972 Dec;46(6):1037–1047. doi: 10.1161/01.cir.46.6.1037. [DOI] [PubMed] [Google Scholar]
  8. Hillis L. D., Braunwald E. Myocardial ischemia (first of three parts). N Engl J Med. 1977 Apr 28;296(17):971–978. doi: 10.1056/NEJM197704282961705. [DOI] [PubMed] [Google Scholar]
  9. Johnsson G., Regårdh C. G. Clinical pharmacokinetics of beta-adrenoreceptors blockers. Drugs. 1976;11(Suppl 1):111–121. doi: 10.2165/00003495-197600111-00026. [DOI] [PubMed] [Google Scholar]
  10. Lee R. J., Evans D. B., Baky S. H., Laffan R. J. Pharmacology of nadolol (SQ 11725), a beta-adrenergic antagonist lacking direct myocardial depression. Eur J Pharmacol. 1975 Sep-Oct;33(2):371–382. doi: 10.1016/0014-2999(75)90182-x. [DOI] [PubMed] [Google Scholar]
  11. Podell R. N., Gary L. R. Hypertension and compliance: implications for the primary physician. N Engl J Med. 1976 May 13;294(20):1120–1121. doi: 10.1056/NEJM197605132942015. [DOI] [PubMed] [Google Scholar]
  12. Prichard B. N. Propranolol in the treatment of angina: a review. Postgrad Med J. 1976;52 (Suppl 4):35–41. [PubMed] [Google Scholar]
  13. Sanne H. Exercise tolerance and physical training of non-selected patients after myocardial infarction. Acta Med Scand Suppl. 1973;551:1–124. [PubMed] [Google Scholar]
  14. Shand D. G. Drug therapy: Propranolol. N Engl J Med. 1975 Aug 7;293(6):280–285. doi: 10.1056/NEJM197508072930606. [DOI] [PubMed] [Google Scholar]
  15. Sharma B., Meeran M. K., Galvin M. C., Tulpule A. T., Whitaker W., Taylor S. H. Comparison of adrenergic beta-blocking drugs in angina pectoris. Br Med J. 1971 Jul 17;3(5767):152–155. doi: 10.1136/bmj.3.5767.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Short D. The management of the patient with angina. Am Heart J. 1977 Aug;94(2):135–139. doi: 10.1016/s0002-8703(77)80271-8. [DOI] [PubMed] [Google Scholar]
  17. Walle T., Gaffney T. E. Propranolol metabolism in man and dog: mass spectrometric identification of six new metabolites. J Pharmacol Exp Ther. 1972 Jul;182(1):83–92. [PubMed] [Google Scholar]
  18. Zweifler A. J., Esler M. Factors influencing the choice of antihypertensive agents. Postgrad Med. 1976 Jul;60(7):81–85. doi: 10.1080/00325481.1976.11714415. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES